Overall verdict
Neutral
5.6/10
1-year performance
-54.37%
Score breakdown
Down 54.4% over 1 year, 8% of the 52-week range.
Strongest: Financial strength 8.4/10. Weakest: Shareholder return 3.2/10.
15 analysts, target +0.4% vs the price.
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Sector
Health Care
Industry
Health Care Providers and Services
Primary listing
Nasdaq
United States
CEO
John Kao
Founded
2013
Employees
1 849
Revenue / employee
2.1M USD
Next earnings
February 25, 2027 (estimated)
Institutional holders
- FMR LLC4.15%
- GEODE CAPITAL MANAGEMENT, LLC2.21%
- Bank of New York Mellon Corp0.87%
- Rest of the register92.77%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
25.12 USD
52-week low
6.01 USD
1-year performance
-54.37%
Declining
Year-to-date performance
-61.90%
Declining
Drawdown
-70.04%
Major drawdown
Position in the 52-week range
8% of range
Range: 8.87 USD - 14.42 USD (2 methods agree)
The price implies growth of 5.28% per year; the company grows at 25.00%.
Net margin 0.6%, ROIC 5.3%, ROE 13.2%.
Net margin
0.59%
Low
Sector 1.68%|S&P 13.40%
Gross margin
—
Return on equity (ROE)
13.17%
Exceptional
Sector 8.65%|S&P 17.06%
Return on invested capital (ROIC)
5.26%
Fair
Free cash flow margin (FCF)
1.56%
Low
Profit-to-cash conversion (FCF conversion)
2.66x
High
Margin stability
5.1 pts
Uneven
Revenue to net income
Growth
4.4/10Revenue up 36.7% over 1 year, 32.7% a year over 5.
Revenue (trailing 12 months)
4.9Md USD
Revenue growth (1y)
36.69%
Hyper-growth
Revenue growth (3y)
175.33%
Hyper-growth
EPS growth (1y)
-316.85%
Declining
EPS CAGR (5y)
—
EPS revisions (3 months)
-46.46%
Sharply revised down
Valuation
3.9/10P/E 57.8x, forward P/E 54.8x, EV/EBITDA 15.6x.
P/E (TTM)
57.8x
Very expensive
Sector 28.8x|S&P 23.6x
Forward P/E
—
N/A (loss)
EV / EBITDA
15.6x
Fair
Sector 18.5x|S&P 15.5x
PEG
—
Sector -0.20|S&P 0.91
Fair value (reverse DCF)
10.47 USD
Undervalued
Market cap
1.6Md USD
Financial strength
8.4/10Cash covers 220.0% of the debt, net debt/EBITDA -5.4x.
Net debt / EBITDA
-5.4x
Net cash
Gearing (net debt / equity)
-144.04%
Net cash
Cash
728M USD
Cash / market cap
46.21%
Very solid
Cash / total debt
220.05%
Net cash
Interest coverage
2.6x
Tight
Net debt
-399M USD
Equity
277M USD
Closed daily candles, 2 years
Last close on November 10, 2026: 7.67 USD
- MM207.92
- MM509.03
- MM20016.26
- RSI 1444.1
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-7.94%
200-day average slope, 3 months
-15.22%
50-day average slope, 1 month
-20.71%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
4.32 % per day
Volatility change
-14.22%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | -0.07 (10) | 0.27 (4) | 5 264 (11) | 103 (10) | -14 (8) |
| 2027 | 0.14 (11) | 0.56 (4) | 6 573 (13) | 165 (12) | 31 (9) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 4, 2026.
Same sub-industry: 10 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PGNY | 7.2 | 7.5 | 2.7Md USD | 33.5x | 6.8 % | 8.9 % | 17.8 % | -3.1x | 6.7 % | 53.4 % | ||
| 2 | HQY | 7.0 | 6.8 | 8.5Md USD | 37.2x | 17.4 % | 7.6 % | 7.7 % | 1.4x | 5.7 % | 3.4 % | ||
| 3 | ELV | 6.8 | 6.7 | 92.8Md USD | 18.3x | 2.5 % | 1.4 % | 6.8 % | 3.0x | 7.0 % | 40.0 % | ||
| 4 | UNH | 6.8 | 6.7 | 361Md USD | 23.0x | 3.5 % | -0.4 % | 9.5 % | 1.8x | 6.3 % | 24.6 % | ||
| 5 | SAUD3 | 6.4 | 5.9 | 8.4Md USD | 16.8x | 10.6 % | 1213.1 % | 10.4 % | -0.3x | 1.5 % | 36.5 % | ||
| 6 | CNC | 5.8 | 5.8 | 34.9Md USD | 24.2x | 0.7 % | 1.9 % | 3.8 % | -1.4x | 11.3 % | 102.9 % | ||
| 7 | ALHC | 5.6 | 5.2 | 1.6Md USD | 57.8x | 0.6 % | 36.7 % | 5.3 % | -5.4x | 4.9 % | -54.4 % | ||
| 8 | HUM | 4.9 | 3.5 | 53.6Md USD | 43.4x | 0.8 % | 26.1 % | 4.1 % | -2.2x | 5.9 % | 86.0 % | ||
| 9 | MOH | 4.7 | 2.8 | 10.9Md USD | Not meaningful (loss) | -0.1 % | -3.4 % | -0.6 % | -22.1x | 2.2 % | 47.1 % |
